| 1. |
Scholten R. J., Bijlmer H. A., Poolman J. T., Kuipers B., Caugant D. A., Van Alphen L., Dankert J., and Valkenburg H. A. (1993)
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new
serotypes and subtypes of Neisseria meningitidis. Clin. Infect. Dis.
6, 237–246.
|
| |
| 2. |
Poolman J. T. (1996) Bacterial outer membrane protein vaccines. The meningococcal example. Adv. Exp. Med. Biol.
397, 73–77.
|
| |
| 3. |
Frasch C. E., Zollinger W. D., and Poolman J. T. (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis.
7, 504–510.
|
| |
| 4. |
Poolman J. T. and Abdillahi H. (1988) Outer membrane protein serosubtyping of Neisseria meningitidis. Eur. J. Clin. Microbiol. Infect. Dis.
7, 291–292.
|
| |
| 5. |
Nato F., Mazie J. C., Fournier J. M., Slizewicz B., Sagot N., Guibourdenche M., Postic D., and Riou J. Y. (1991) Production
of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents. J. Clin. Microbiol.
29, 1447–1452.
|
| |
| 6. |
Scholten R. J., Kuipers B., Valkenburg H. A., Dankert J., Zollinger W. D., and Poolman J. T. (1994) Lipo-oligosaccharide immunotyping
of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J. Med. Microbiol.
41, 236–243.
|
| |
| 7. |
Danelli M. G., Batoreu N. M., Lacerda M. D., Ferreira C. R., Cardoso J. D., Peralta J. M., and Frasch C. E. (1995) Surface
antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein. Curr. Microbiol.
31, 146–151.
|
| |
| 8. |
Cadieux N., Plante M., Rioux C. R., Hamel J., Brodeur B. R., and Martin D. (1999) Bactericidal and cross-protective activities
of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein. Infect. Immun.
67, 4955–4959.
|
| |
| 9. |
McGuinness B., Barlow A. K., Clarke I. N., Farley J. E., Anilionis A., Poolman J. T., and Heckels J. E. (1990) Deduced amino
acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity. J. Exp. Med.
171, 1871–1882.
|
| |
| 10. |
van der Ley P., Heckels J. E., Virji M., Hoogerhout P., and Poolman J. T. (1991) Topology of outer membrane porins in pathogenic
Neisseria spp. Infect. Immun.
59, 2963–2971.
|
| |
| 11. |
Maiden M. C., Suker J., McKenna A. J., Bygraves J. A., and Feavers I. M. (1991) Comparison of the class 1 outer membrane proteins
of eight serological reference strains of Neisseria meningitidis. Mol. Microbiol.
5, 727–736.
|
| |
| 12. |
Jennings M. P., Srikhanta Y. N., Moxon E. R., Kramer M., Poolman J. T., Kuipers B., and van der Ley P. (1999) The genetic
basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology
145, 3013–3021.
|
| |
| 13. |
Poolman J. T., Kriz-Kuzemenska P., Ashton F., Bibb W., Dankert J., Demina A., Froholm L. O., Hassan-King M., Jones D. M.,
and Lind I. (1995) Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin. Diagn. Lab. Immunol.
2, 69–72.
|
| |
| 14. |
Rosenqvist E., Wedege E., Hoiby E. A., and Froholm L. O. (1990) Serogroup determination of Neisseria meningitidis by whole-cell
ELISA, dot-blotting and agglutination. APMIS
98, 501–506.
|
| |
| 15. |
Sacchi C. T., Lemos A. P., Whitney A. M., Solari C. A., Brandt M. E., Melles C. E., Frasch C. E., and Mayer L. W. (1998) Correlation
between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin. Diagn. Lab. Immunol.
5, 348–354.
|
| |
| 16. |
Sacchi C. T., Lemos A. P., Brandt M. E., Whitney A. M., Melles C. E., Solari C. A., Frasch C. E., and Mayer L. W. (1998) Proposed
standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol.
5, 845–855.
|
| |
| 17. |
Zollinger W. D., Moran E. E., Connelly H., Mandrell R. E., and Brandt B. (1984) Monoclonal antibodies to serotype 2 and serotype
15 outer membrane proteins of Neisseria meningitidis and their use in serotyping. Infect. Immun.
46, 260–266.
|
| |
| 18. |
Wedege E., Hoiby E. A., Rosenqvist E., and Froholm L. O. (1990) Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J. Med. Microbiol.
31, 195–201.
|
| |
| 19. |
Wedege E., Caugant D. A., Froholm L. O., and Zollinger W. D. (1991) Charac-terization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis. J. Clin. Microbiol.
29, 1486–1492.
|
| |
| 20. |
Urwin R., Feavers I. M., Jones D. M., Maiden M. C., and Fox A. J. (1998) Molecular variation of meningococcal serotype 4 antigen
genes. Epidemiol. Infect.
121, 95–101.
|
| |
| 21. |
Feavers I. M., Fox A. J., Gray S., Jones D. M., and Maiden M. C. (1996) Antigenic diversity of meningococcal outer membrane
protein PorA has implications for epidemiological analysis and vaccine design. Clin. Diagn. Lab. Immunol.
3, 444–450.
|
| |
| 22. |
van der Ende A., Hopman C. T., Zaat S., Essink B. B., Berkhout B., and Dankert J. (1995) Variable expression of class 1 outer
membrane protein in Neisseria meningitidis is caused by variation in the spacing between the −10 and −35 regions of the promoter. J. Bacteriol.
177, 2475–2480.
|
| |
| 23. |
Maiden M. C., Bygraves J. A., McCarvil J., and Feavers I. M. (1992) Identification of meningococcal serosubtypes by polymerase
chain reaction. J. Clin. Microbiol.
30, 2835–2841.
|
| |
| 24. |
Feavers I. M., Suker J., McKenna A. J., Heath A. B., and Maiden M. C. (1992) Molecular analysis of the serotyping antigens
of Neisseria meningitidis. Infect. Immun.
60, 3620–3629.
|
| |
| 25. |
Achtman M., Wall R. A., Bopp M., Kusecek B., Morelli G., Saken E., and Hassan-King M. (1991) Variation in class 5 protein
expression by serogroup A meningococci during a meningitis epidemic. J. Infect. Dis.
164, 375–382.
|
| |
| 26. |
van der Ley P., van der Biezen J., and Poolman J. T. (1995) Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle
vaccine. Vaccine
13, 401–407.
|
| |
| 27. |
Schneider H., Hammack C. A., Apicella M. A., and Griffiss J. M. (1988) Instability of expression of lipooligosaccharides and
their epitopes in Neisseria gonorrhoeae. Infect. Immun.
56, 942–946.
|
| |
| 28. |
van der Ley P. and Poolman J. T. (1992) Construction of a multivalent meningococcal vaccine strain based on the class 1 outer
membrane protein. Infect. Immun.
60, 3156–3161.
|
| |
| 29. |
van der Ley P., van der Biezen J., Hohenstein P., Peeters C., and Poolman J. T. (1993) Use of transformation to construct
antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect. Immun.
61, 4217–4224.
|
| |
| 30. |
Moran E. E., Brandt B. L., and Zollinger W. D. (1994) Expression of the L8 lipopolysaccharide determinant increases the sensitivity
of Neisseria meningitidis to serum bactericidal activity. Infect. Immun.
62, 5290–5295.
|
| |
| 31. |
Pettersson A., Kuipers B., Pelzer M., Verhagen E., Tiesjema R. H., Tommassen J., and Poolman J. T. (1990) Monoclonal antibodies
against the 70-kilodalton ironregulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect. Immun.
58, 3036–3041.
|
| |
| 32. |
Rouppe van der Voort E., van der Ley P., van der Biezen J., George S., Tunnela O., van Dijken H., Kuipers B., and Poolman
J. (1996) Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer
membrane vesicle vaccine. Infect. Immun.
64, 2745–2751.
|
| |
| 33. |
Lesse A. J., Campagnari A. A., Bittner W. E., and Apicella M. A. (1990) Increased resolution of lipopolysaccharides and lipooligosaccharides
utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods
126, 109–117.
|
| |
| 34. |
Lee N., Yang J. S., and Testa D. (1988) A simplified high speed multicolor immunoblotting method. Anal. Biochem.
175, 30–34.
|
| |
| 35. |
Wedege E., Dalseg R., Caugant D. A., Poolman J. T., and Froholm L. O. (1993) Expression of an inaccessible P1.7 subtype epitope
on meningococcal class 1 proteins. J. Med. Microbiol.
38, 23–28.
|
| |
| 36. |
Bitter-Suermann D. and Roth J. (1987) Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic
bacteria, differentiating cells and tumor cells. Immunol. Res.
6, 225–237.
|
| |
| 37. |
Hurpin C. M., Carosella E. D., and Cazenave P. A. (1992) Bactericidal activity of two IgG2a murine monoclonal antibodies with
distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide. Hybridoma
11, 677–687.
|
| |
| 38. |
Munkley A., Tinsley C. R., Virji M., and Heckels J. E. (1991) Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb. Pathog.
11, 447–452.
|
| |
| 39. |
Rosenqvist E., Musacchio A., Aase A., Hoiby E. A., Namork E., Kolberg J., et al. (1999) Functional activities and epitope
specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis. Infect. Immun.
67, 1267–1276.
|
| |
| 40. |
Martin D., Cadieux N., Hamel J., and Brodeur B. R. (1997) Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J. Exp. Med.
185, 1173–1183.
|
| |
| 41. |
Gu X. X., Tsai C. M., and Karpas A. B. (1992) Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide
of Neisseria meningitidis. J. Clin. Microbiol.
30, 2047–2053.
|
| |
| 42. |
Verheul A. F., Kuipers A. J., Braat A. K., Dekker H. A., Peeters C. C., Snippe H., and Poolman J. T. (1994) Development, characterization,
and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies. Clin. Diagn. Lab. Immunol.
1, 729–736.
|
| |
| 43. |
Ala’Aldeen D. A., Davies H. A., and Borriello S. P. (1994) Vaccine potential of meningococcal FrpB: studies on surface exposure
and functional attributes of common epitopes. Vaccine
12, 535–541.
|
| |
| 44. |
Pettersson A., van der Ley P., Poolman J. T., and Tommassen J. (1993) Molecular characterization of the 98-kilodalton iron-regulated
outer membrane protein of Neisseria meningitidis. Infect. Immun.
61, 4724–4733.
|
| |